Cefdinirversus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: A multicenter, randomized, double-blind studyHENRY, Dan C; KAPRAL, Dolores; BUSMAN, Todd A et al.Clinical therapeutics. 2004, Vol 26, Num 12, pp 2026-2033, issn 0149-2918, 8 p.Article

Changes in frequency and pathogens causing acute otitis media in 1995-2003. CommentaryCASEY, Janet R; PICHICHERO, Michael E; PARIS, Maria M et al.The Pediatric infectious disease journal. 2004, Vol 23, Num 9, pp 824-841, issn 0891-3668, 18 p.Article

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRUDIN, Charles M; HANN, Christine L; RANSON, Malcolm R et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, issn 1078-0432, 7 p.Article

A controlled, double-blind, multicenter study comparing Clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumoniaGOTFRIED, Mark H; DATTANI, Dan; RIFFER, Ernie et al.Clinical therapeutics. 2002, Vol 24, Num 5, pp 736-751, issn 0149-2918Article

Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory DiseaseROBERTS, Andrew W; SEYMOUR, John F; YUE CUI et al.Journal of clinical oncology. 2012, Vol 30, Num 5, pp 488-496, issn 0732-183X, 9 p.Article

A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumoniaSOKOL, William N; SULLIVAN, James G; ACAMPORA, Matthew D et al.Clinical therapeutics. 2002, Vol 24, Num 4, pp 605-615, issn 0149-2918Article